Factsheet - Network reporting via the European Shortages Monitoring Platform (ESMP) during a crisis

Factsheet - Network reporting via the European Shortages Monitoring Platform (ESMP) during an MSSG-led preparedness action

Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) in normal circumstances

Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) in normal circumstances

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Ventavis, iloprost, Date of authorisation: 15/09/2003, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Cyanokit, hydroxocobalamin, Date of authorisation: 23/11/2007, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Opsumit, macitentan, Date of authorisation: 20/12/2013, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Cholib, fenofibrate,simvastatin, Date of authorisation: 26/08/2013, Revision: 18, Status: Authorised